Cancer and biomarkers
Microfluidics and Tumor DNA - Contribution of digital PCR
Research and innovation REF: RE241 V1
Cancer and biomarkers
Microfluidics and Tumor DNA - Contribution of digital PCR

Authors : Philippe NIZARD, Aurélie KROL, Pierre LAURENT-PUIG, Valérie TALY

Publication date: February 10, 2015 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

2. Cancer and biomarkers

In recent years, cancer has become the leading cause of death, overtaking cardiovascular disease. It is the cause of a third of male deaths and a quarter of female deaths. In 2012 in France, 355,000 new cases of cancer were diagnosed, and 148,000 people died from it.

Cancer is a disease in which certain abnormal cells multiply anarchically, acquiring the ability to infiltrate and destroy healthy tissue to form a tumor. New sequencing technologies have revealed a complex network of genetic alterations present in cancer cells and absent from healthy cells. Depending on the alterations present, the prognosis and response to treatment may differ. As a result, early detection of these alterations now makes it possible to propose the most appropriate treatment, within the framework of so-called "targeted" therapies.

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Article included in this offer

"Bioprocesses and bioproductions"

( 138 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details